Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Final data backs early findings, WHO recommendations, showing shorter MDR TB treatment course working better

Presenting results today of a nine month treatment regimen that led to an 82 percent cure rate among 1006 patients with multidrug-resistant tuberculosis, researchers called their findings a breakthrough that can support countries in adopting shorter, more effective and potentially less damaging treatment for TB that is resistant to more than one first line treatment.

Published
26 October 2016
From
Science Speaks
47th Union World Conference on Lung Health: Even “free” TB treatment can come with catastrophic costs

Even before the costs of getting diagnosed, picked up in some high-tuberculosis incidence countries by patients themselves, and even before treatment brings its own costs, the financial toll of tuberculosis has already begun, a representative of the World Health Organization said today.

Published
26 October 2016
From
Science Speaks
2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time To Lose

Tuberculosis (TB) killed 1.8 million people in 2015, making it the most deadly infectious disease worldwide, but funding for research into better TB prevention, diagnosis, and treatment dropped by US$53.4 million, according to Treatment Action Group’s 2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose.

Published
26 October 2016
From
Treatment Action Group
Access: MSF reports on use of the new tuberculosis drugs bedaquiline and delamanid

Access to the new tuberculosis (TB) drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continues.

Published
26 October 2016
From
Médecins Sans Frontières (MSF) International
‘True Scale’ of India’s Tuberculosis Problem: 2.8 Million New Cases

Finally coming to terms with the enormity of its tuberculosis problem, India is preparing a radical overhaul and expansion of its national treatment program to fight an affliction that kills more adults worldwide than any other infectious disease.

Published
17 October 2016
From
New York Times
Latent TB high in India's healthcare workers

While India continues to have the highest burden of tuberculosis in the world, about 23 per cent of the 8.7 million global incidences, a study reports nearly half of its healthcare workers taking care of TB patients also suffer from latent tuberculosis.

Published
17 October 2016
From
SciDevNet
WHO report warns global actions and investments to end tuberculosis epidemic are falling far short

New data published by WHO in its 2016 "Global Tuberculosis Report" show that countries need to move much faster to prevent, detect, and treat the disease if they are to meet global targets.

Published
14 October 2016
From
World Health Organization
The Lancet: Migrants screened for active tuberculosis pose negligible risk of spreading infection but can still get disease later

Tuberculosis incidence in the UK has declined over the past four years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

Published
13 October 2016
From
Eurekalert Medicine & Health
TB drugs may be disrupted by botanical supplement, MU researchers find

MU researchers, working with scientists in Africa, discovered that a widely used African botanical supplement called Sutherlandia — traditionally taken to prevent or treat symptoms of infections — may actually disrupt the effectiveness of a common anti-tuberculosis drug, isoniazid.

Published
11 October 2016
From
Kansas City Star
Zimbabwe study sees TB go down as HIV treatment coverage goes up

As the numbers of people accessing HIV treatment went up in Zimbabwe, the numbers of reported tuberculosis cases were cut nearly in half.

Published
06 October 2016
From
Science Speaks

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.